Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    AMXT-1501 dicaprate

    DEVELOPMENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: T9gpe23kz9, Chembl6068506, 2135609-32-2, Decanoic acid, compd. with n-[(5r)-5-amino-6-[[3-[[4-[(3-aminopropyl)amino]butyl]amino]propyl]amino]-6-oxohexyl]hexadecanamide (2:1)
    Molecular Formula
    C52H108N6O6
    Molecular Weight
    913.5  g/mol
    InChI Key
    PMQBHPUZUKOTJJ-ZHXNKHNVSA-N
    FDA UNII
    T9GPE23KZ9
    Polyamine Transport Inhibitor AMXT-1501 Dicaprate is the dicaprate salt form of AMXT-1501, an orally bioavailable polyamine transport inhibitor, with immunostimulating and antineoplastic activities. Upon administration, AMXT-1501 targets, binds to and blocks polyamine transport from the bloodstream into the tumor microenvironment (TME), thereby preventing cancer cell uptake. This decreases polyamine concentrations inside the TME and tumor cell, inhibits tumor cell proliferation and induces apoptosis. In addition, AMXT-1501 may abrogate polyamine-mediated immune suppression in the TME. Polyamines, naturally found in normal, heathy cells, are required for normal cell growth and division. In cancer cells, polyamines play key roles in tumor cell proliferation and tumor-induced suppression of the patient's immune system.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    N-[(5R)-5-amino-6-[3-[4-(3-aminopropylamino)butylamino]propylamino]-6-oxohexyl]hexadecanamide;bis(decanoic acid)
    2.1.2 InChI
    InChI=1S/C32H68N6O2.2C10H20O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-22-31(39)37-28-16-15-21-30(34)32(40)38-29-20-27-36-25-18-17-24-35-26-19-23-33;2*1-2-3-4-5-6-7-8-9-10(11)12/h30,35-36H,2-29,33-34H2,1H3,(H,37,39)(H,38,40);2*2-9H2,1H3,(H,11,12)/t30-;;/m1../s1
    2.1.3 InChI Key
    PMQBHPUZUKOTJJ-ZHXNKHNVSA-N
    2.2 Other Identifiers
    2.2.1 UNII
    T9GPE23KZ9
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. T9gpe23kz9

    2. Chembl6068506

    3. 2135609-32-2

    4. Decanoic Acid, Compd. With N-[(5r)-5-amino-6-[[3-[[4-[(3-aminopropyl)amino]butyl]amino]propyl]amino]-6-oxohexyl]hexadecanamide (2:1)

    2.4 Create Date
    2024-01-03
    3 Chemical and Physical Properties
    Molecular Weight 913.5 g/mol
    Molecular Formula C52H108N6O6
    Hydrogen Bond Donor Count8
    Hydrogen Bond Acceptor Count10
    Rotatable Bond Count48
    Exact Mass Da
    Monoisotopic Mass Da
    Topological Polar Surface Area209
    Heavy Atom Count64
    Formal Charge0
    Complexity660
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count3
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.